Pleryon Therapeutics (hangzhou) Limited

This study tests a new lubricating eye drop called ABR2 for people with dry eye syndrome. Forty adults will use the drop for up to 28 days to see if it is safe and comfortable. The study does not compare the drop to a placebo. The goal is to ease dry eye discomfort.